Global Simvastatin Market
Global Simvastatin Market

Simvastatin Comprehensive Study by Type (Enzymatic Synthesis, Chemical Synthesis), Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Form type (Tablet, Capsule) Players and Region - Global Market Outlook to 2024

Simvastatin Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Mar 2020 Edition 228 Pages 163 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Simvastatin Market Overview:
Simvastatin is the class of statins that lowers blood cholesterols level in the body. This is used to treat bad cholesterol levels in the body by inhibiting HMG coenzyme reductase.

Market Drivers
  • Increasing Number of Cholesterol Cases Due to Sedentary Lifestyle and Rising Work-Pressures

Market Trend
  • PKU Healthcare
  • Zhejiang Guobang
  • Huayi Pharma
  • Apeloa Kangyu
  • Southwest Pharmaceutical
  • Xinchang Pharmaceutical
  • Hailing Chemipharma
  • Bj Winsunny
  • Lianhuan

Restraints
  • Over Excessive Side Effects with Simvastatin That Could Be Life-Threatening and Headaches, Difficulty in Sleeping, Abdominal Cramping, Nausea or Vomiting, Hunger Or Dry Mouth Are Long-Term Side Effects of Simvastatin

Opportunities
  • Increase in R&D Activities in the Field of Pharmaceutical Industries and Rise in Therapeutical Applications

Challenges
  • Availability of Substitutes in the Emerging Region


Competitive Landscape:

Some of the key players profiled in the report are Pfizer Inc. (United States), AstraZeneca (United Kingdom), Novartis (Switzerland), Merck & Co. Inc. (United States), Biocon (India), GlaxoSmithKline Plc. (United Kingdom), Concord Biotech (India), Sun Pharma (India) and Abbott Laboratories (United States). Additionally, following companies can also be profiled that are part of our coverage like Shandong Lukang Pharmaceutical Co., Ltd (China), Zhejiang Ruibang (China) and Aurobindo Pharma Ltd. (India). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Simvastatin market by 2024. Considering Market by Form type, the sub-segment i.e. Tablet will boost the Simvastatin market.

In the U.S., over 500,000 people suffer a heart attack every year. Though cholesterol level is easy to maintain provided one follows a healthy diet, a sedentary lifestyle has been a major challenge for over the last several years. As such, over a quarter of the Americans in the U.S. take statins to lower down the cholesterol level.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Simvastatin market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Simvastatin market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Regulatory Bodies, Including Government Agencies And NGOs, Commercial Research & Development (R&D) Institutions, Government Organizations, Research Organizations, And Consulting Firms and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Enzymatic Synthesis
  • Chemical Synthesis
By Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
By Form type
  • Tablet
  • Capsule

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Cholesterol Cases Due to Sedentary Lifestyle and Rising Work-Pressures
    • 3.3. Market Challenges
      • 3.3.1. Availability of Substitutes in the Emerging Region
    • 3.4. Market Trends
      • 3.4.1. PKU Healthcare
      • 3.4.2. Zhejiang Guobang
      • 3.4.3. Huayi Pharma
      • 3.4.4. Apeloa Kangyu
      • 3.4.5. Southwest Pharmaceutical
      • 3.4.6. Xinchang Pharmaceutical
      • 3.4.7. Hailing Chemipharma
      • 3.4.8. Bj Winsunny
      • 3.4.9. Lianhuan
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Simvastatin, by Type, Application, Form type and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Simvastatin (Value)
      • 5.2.1. Global Simvastatin by: Type (Value)
        • 5.2.1.1. Enzymatic Synthesis
        • 5.2.1.2. Chemical Synthesis
      • 5.2.2. Global Simvastatin by: Application (Value)
        • 5.2.2.1. Hospital Pharmacy
        • 5.2.2.2. Retail Pharmacy
        • 5.2.2.3. Online Pharmacy
      • 5.2.3. Global Simvastatin by: Form type (Value)
        • 5.2.3.1. Tablet
        • 5.2.3.2. Capsule
      • 5.2.4. Global Simvastatin Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Simvastatin (Price)
      • 5.3.1. Global Simvastatin by: Type (Price)
  • 6. Simvastatin: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Pfizer Inc. (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. AstraZeneca (United Kingdom)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Novartis (Switzerland)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Merck & Co. Inc. (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Biocon (India)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. GlaxoSmithKline Plc. (United Kingdom)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Concord Biotech (India)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Sun Pharma (India)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Abbott Laboratories (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
  • 7. Global Simvastatin Sale, by Type, Application, Form type and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Simvastatin (Value)
      • 7.2.1. Global Simvastatin by: Type (Value)
        • 7.2.1.1. Enzymatic Synthesis
        • 7.2.1.2. Chemical Synthesis
      • 7.2.2. Global Simvastatin by: Application (Value)
        • 7.2.2.1. Hospital Pharmacy
        • 7.2.2.2. Retail Pharmacy
        • 7.2.2.3. Online Pharmacy
      • 7.2.3. Global Simvastatin by: Form type (Value)
        • 7.2.3.1. Tablet
        • 7.2.3.2. Capsule
      • 7.2.4. Global Simvastatin Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Simvastatin (Price)
      • 7.3.1. Global Simvastatin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Simvastatin: by Type(USD Million)
  • Table 2. Simvastatin Enzymatic Synthesis , by Region USD Million (2013-2018)
  • Table 3. Simvastatin Chemical Synthesis , by Region USD Million (2013-2018)
  • Table 4. Simvastatin: by Application(USD Million)
  • Table 5. Simvastatin Hospital Pharmacy , by Region USD Million (2013-2018)
  • Table 6. Simvastatin Retail Pharmacy , by Region USD Million (2013-2018)
  • Table 7. Simvastatin Online Pharmacy , by Region USD Million (2013-2018)
  • Table 8. Simvastatin: by Form type(USD Million)
  • Table 9. Simvastatin Tablet , by Region USD Million (2013-2018)
  • Table 10. Simvastatin Capsule , by Region USD Million (2013-2018)
  • Table 11. South America Simvastatin, by Country USD Million (2013-2018)
  • Table 12. South America Simvastatin, by Type USD Million (2013-2018)
  • Table 13. South America Simvastatin, by Application USD Million (2013-2018)
  • Table 14. South America Simvastatin, by Form type USD Million (2013-2018)
  • Table 15. Brazil Simvastatin, by Type USD Million (2013-2018)
  • Table 16. Brazil Simvastatin, by Application USD Million (2013-2018)
  • Table 17. Brazil Simvastatin, by Form type USD Million (2013-2018)
  • Table 18. Argentina Simvastatin, by Type USD Million (2013-2018)
  • Table 19. Argentina Simvastatin, by Application USD Million (2013-2018)
  • Table 20. Argentina Simvastatin, by Form type USD Million (2013-2018)
  • Table 21. Rest of South America Simvastatin, by Type USD Million (2013-2018)
  • Table 22. Rest of South America Simvastatin, by Application USD Million (2013-2018)
  • Table 23. Rest of South America Simvastatin, by Form type USD Million (2013-2018)
  • Table 24. Asia Pacific Simvastatin, by Country USD Million (2013-2018)
  • Table 25. Asia Pacific Simvastatin, by Type USD Million (2013-2018)
  • Table 26. Asia Pacific Simvastatin, by Application USD Million (2013-2018)
  • Table 27. Asia Pacific Simvastatin, by Form type USD Million (2013-2018)
  • Table 28. China Simvastatin, by Type USD Million (2013-2018)
  • Table 29. China Simvastatin, by Application USD Million (2013-2018)
  • Table 30. China Simvastatin, by Form type USD Million (2013-2018)
  • Table 31. Japan Simvastatin, by Type USD Million (2013-2018)
  • Table 32. Japan Simvastatin, by Application USD Million (2013-2018)
  • Table 33. Japan Simvastatin, by Form type USD Million (2013-2018)
  • Table 34. India Simvastatin, by Type USD Million (2013-2018)
  • Table 35. India Simvastatin, by Application USD Million (2013-2018)
  • Table 36. India Simvastatin, by Form type USD Million (2013-2018)
  • Table 37. South Korea Simvastatin, by Type USD Million (2013-2018)
  • Table 38. South Korea Simvastatin, by Application USD Million (2013-2018)
  • Table 39. South Korea Simvastatin, by Form type USD Million (2013-2018)
  • Table 40. Taiwan Simvastatin, by Type USD Million (2013-2018)
  • Table 41. Taiwan Simvastatin, by Application USD Million (2013-2018)
  • Table 42. Taiwan Simvastatin, by Form type USD Million (2013-2018)
  • Table 43. Australia Simvastatin, by Type USD Million (2013-2018)
  • Table 44. Australia Simvastatin, by Application USD Million (2013-2018)
  • Table 45. Australia Simvastatin, by Form type USD Million (2013-2018)
  • Table 46. Rest of Asia-Pacific Simvastatin, by Type USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Simvastatin, by Application USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Simvastatin, by Form type USD Million (2013-2018)
  • Table 49. Europe Simvastatin, by Country USD Million (2013-2018)
  • Table 50. Europe Simvastatin, by Type USD Million (2013-2018)
  • Table 51. Europe Simvastatin, by Application USD Million (2013-2018)
  • Table 52. Europe Simvastatin, by Form type USD Million (2013-2018)
  • Table 53. Germany Simvastatin, by Type USD Million (2013-2018)
  • Table 54. Germany Simvastatin, by Application USD Million (2013-2018)
  • Table 55. Germany Simvastatin, by Form type USD Million (2013-2018)
  • Table 56. France Simvastatin, by Type USD Million (2013-2018)
  • Table 57. France Simvastatin, by Application USD Million (2013-2018)
  • Table 58. France Simvastatin, by Form type USD Million (2013-2018)
  • Table 59. Italy Simvastatin, by Type USD Million (2013-2018)
  • Table 60. Italy Simvastatin, by Application USD Million (2013-2018)
  • Table 61. Italy Simvastatin, by Form type USD Million (2013-2018)
  • Table 62. United Kingdom Simvastatin, by Type USD Million (2013-2018)
  • Table 63. United Kingdom Simvastatin, by Application USD Million (2013-2018)
  • Table 64. United Kingdom Simvastatin, by Form type USD Million (2013-2018)
  • Table 65. Netherlands Simvastatin, by Type USD Million (2013-2018)
  • Table 66. Netherlands Simvastatin, by Application USD Million (2013-2018)
  • Table 67. Netherlands Simvastatin, by Form type USD Million (2013-2018)
  • Table 68. Rest of Europe Simvastatin, by Type USD Million (2013-2018)
  • Table 69. Rest of Europe Simvastatin, by Application USD Million (2013-2018)
  • Table 70. Rest of Europe Simvastatin, by Form type USD Million (2013-2018)
  • Table 71. MEA Simvastatin, by Country USD Million (2013-2018)
  • Table 72. MEA Simvastatin, by Type USD Million (2013-2018)
  • Table 73. MEA Simvastatin, by Application USD Million (2013-2018)
  • Table 74. MEA Simvastatin, by Form type USD Million (2013-2018)
  • Table 75. Middle East Simvastatin, by Type USD Million (2013-2018)
  • Table 76. Middle East Simvastatin, by Application USD Million (2013-2018)
  • Table 77. Middle East Simvastatin, by Form type USD Million (2013-2018)
  • Table 78. Africa Simvastatin, by Type USD Million (2013-2018)
  • Table 79. Africa Simvastatin, by Application USD Million (2013-2018)
  • Table 80. Africa Simvastatin, by Form type USD Million (2013-2018)
  • Table 81. North America Simvastatin, by Country USD Million (2013-2018)
  • Table 82. North America Simvastatin, by Type USD Million (2013-2018)
  • Table 83. North America Simvastatin, by Application USD Million (2013-2018)
  • Table 84. North America Simvastatin, by Form type USD Million (2013-2018)
  • Table 85. United States Simvastatin, by Type USD Million (2013-2018)
  • Table 86. United States Simvastatin, by Application USD Million (2013-2018)
  • Table 87. United States Simvastatin, by Form type USD Million (2013-2018)
  • Table 88. Canada Simvastatin, by Type USD Million (2013-2018)
  • Table 89. Canada Simvastatin, by Application USD Million (2013-2018)
  • Table 90. Canada Simvastatin, by Form type USD Million (2013-2018)
  • Table 91. Mexico Simvastatin, by Type USD Million (2013-2018)
  • Table 92. Mexico Simvastatin, by Application USD Million (2013-2018)
  • Table 93. Mexico Simvastatin, by Form type USD Million (2013-2018)
  • Table 94. Simvastatin: by Type(USD/Units)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Simvastatin: by Type(USD Million)
  • Table 105. Simvastatin Enzymatic Synthesis , by Region USD Million (2019-2024)
  • Table 106. Simvastatin Chemical Synthesis , by Region USD Million (2019-2024)
  • Table 107. Simvastatin: by Application(USD Million)
  • Table 108. Simvastatin Hospital Pharmacy , by Region USD Million (2019-2024)
  • Table 109. Simvastatin Retail Pharmacy , by Region USD Million (2019-2024)
  • Table 110. Simvastatin Online Pharmacy , by Region USD Million (2019-2024)
  • Table 111. Simvastatin: by Form type(USD Million)
  • Table 112. Simvastatin Tablet , by Region USD Million (2019-2024)
  • Table 113. Simvastatin Capsule , by Region USD Million (2019-2024)
  • Table 114. South America Simvastatin, by Country USD Million (2019-2024)
  • Table 115. South America Simvastatin, by Type USD Million (2019-2024)
  • Table 116. South America Simvastatin, by Application USD Million (2019-2024)
  • Table 117. South America Simvastatin, by Form type USD Million (2019-2024)
  • Table 118. Brazil Simvastatin, by Type USD Million (2019-2024)
  • Table 119. Brazil Simvastatin, by Application USD Million (2019-2024)
  • Table 120. Brazil Simvastatin, by Form type USD Million (2019-2024)
  • Table 121. Argentina Simvastatin, by Type USD Million (2019-2024)
  • Table 122. Argentina Simvastatin, by Application USD Million (2019-2024)
  • Table 123. Argentina Simvastatin, by Form type USD Million (2019-2024)
  • Table 124. Rest of South America Simvastatin, by Type USD Million (2019-2024)
  • Table 125. Rest of South America Simvastatin, by Application USD Million (2019-2024)
  • Table 126. Rest of South America Simvastatin, by Form type USD Million (2019-2024)
  • Table 127. Asia Pacific Simvastatin, by Country USD Million (2019-2024)
  • Table 128. Asia Pacific Simvastatin, by Type USD Million (2019-2024)
  • Table 129. Asia Pacific Simvastatin, by Application USD Million (2019-2024)
  • Table 130. Asia Pacific Simvastatin, by Form type USD Million (2019-2024)
  • Table 131. China Simvastatin, by Type USD Million (2019-2024)
  • Table 132. China Simvastatin, by Application USD Million (2019-2024)
  • Table 133. China Simvastatin, by Form type USD Million (2019-2024)
  • Table 134. Japan Simvastatin, by Type USD Million (2019-2024)
  • Table 135. Japan Simvastatin, by Application USD Million (2019-2024)
  • Table 136. Japan Simvastatin, by Form type USD Million (2019-2024)
  • Table 137. India Simvastatin, by Type USD Million (2019-2024)
  • Table 138. India Simvastatin, by Application USD Million (2019-2024)
  • Table 139. India Simvastatin, by Form type USD Million (2019-2024)
  • Table 140. South Korea Simvastatin, by Type USD Million (2019-2024)
  • Table 141. South Korea Simvastatin, by Application USD Million (2019-2024)
  • Table 142. South Korea Simvastatin, by Form type USD Million (2019-2024)
  • Table 143. Taiwan Simvastatin, by Type USD Million (2019-2024)
  • Table 144. Taiwan Simvastatin, by Application USD Million (2019-2024)
  • Table 145. Taiwan Simvastatin, by Form type USD Million (2019-2024)
  • Table 146. Australia Simvastatin, by Type USD Million (2019-2024)
  • Table 147. Australia Simvastatin, by Application USD Million (2019-2024)
  • Table 148. Australia Simvastatin, by Form type USD Million (2019-2024)
  • Table 149. Rest of Asia-Pacific Simvastatin, by Type USD Million (2019-2024)
  • Table 150. Rest of Asia-Pacific Simvastatin, by Application USD Million (2019-2024)
  • Table 151. Rest of Asia-Pacific Simvastatin, by Form type USD Million (2019-2024)
  • Table 152. Europe Simvastatin, by Country USD Million (2019-2024)
  • Table 153. Europe Simvastatin, by Type USD Million (2019-2024)
  • Table 154. Europe Simvastatin, by Application USD Million (2019-2024)
  • Table 155. Europe Simvastatin, by Form type USD Million (2019-2024)
  • Table 156. Germany Simvastatin, by Type USD Million (2019-2024)
  • Table 157. Germany Simvastatin, by Application USD Million (2019-2024)
  • Table 158. Germany Simvastatin, by Form type USD Million (2019-2024)
  • Table 159. France Simvastatin, by Type USD Million (2019-2024)
  • Table 160. France Simvastatin, by Application USD Million (2019-2024)
  • Table 161. France Simvastatin, by Form type USD Million (2019-2024)
  • Table 162. Italy Simvastatin, by Type USD Million (2019-2024)
  • Table 163. Italy Simvastatin, by Application USD Million (2019-2024)
  • Table 164. Italy Simvastatin, by Form type USD Million (2019-2024)
  • Table 165. United Kingdom Simvastatin, by Type USD Million (2019-2024)
  • Table 166. United Kingdom Simvastatin, by Application USD Million (2019-2024)
  • Table 167. United Kingdom Simvastatin, by Form type USD Million (2019-2024)
  • Table 168. Netherlands Simvastatin, by Type USD Million (2019-2024)
  • Table 169. Netherlands Simvastatin, by Application USD Million (2019-2024)
  • Table 170. Netherlands Simvastatin, by Form type USD Million (2019-2024)
  • Table 171. Rest of Europe Simvastatin, by Type USD Million (2019-2024)
  • Table 172. Rest of Europe Simvastatin, by Application USD Million (2019-2024)
  • Table 173. Rest of Europe Simvastatin, by Form type USD Million (2019-2024)
  • Table 174. MEA Simvastatin, by Country USD Million (2019-2024)
  • Table 175. MEA Simvastatin, by Type USD Million (2019-2024)
  • Table 176. MEA Simvastatin, by Application USD Million (2019-2024)
  • Table 177. MEA Simvastatin, by Form type USD Million (2019-2024)
  • Table 178. Middle East Simvastatin, by Type USD Million (2019-2024)
  • Table 179. Middle East Simvastatin, by Application USD Million (2019-2024)
  • Table 180. Middle East Simvastatin, by Form type USD Million (2019-2024)
  • Table 181. Africa Simvastatin, by Type USD Million (2019-2024)
  • Table 182. Africa Simvastatin, by Application USD Million (2019-2024)
  • Table 183. Africa Simvastatin, by Form type USD Million (2019-2024)
  • Table 184. North America Simvastatin, by Country USD Million (2019-2024)
  • Table 185. North America Simvastatin, by Type USD Million (2019-2024)
  • Table 186. North America Simvastatin, by Application USD Million (2019-2024)
  • Table 187. North America Simvastatin, by Form type USD Million (2019-2024)
  • Table 188. United States Simvastatin, by Type USD Million (2019-2024)
  • Table 189. United States Simvastatin, by Application USD Million (2019-2024)
  • Table 190. United States Simvastatin, by Form type USD Million (2019-2024)
  • Table 191. Canada Simvastatin, by Type USD Million (2019-2024)
  • Table 192. Canada Simvastatin, by Application USD Million (2019-2024)
  • Table 193. Canada Simvastatin, by Form type USD Million (2019-2024)
  • Table 194. Mexico Simvastatin, by Type USD Million (2019-2024)
  • Table 195. Mexico Simvastatin, by Application USD Million (2019-2024)
  • Table 196. Mexico Simvastatin, by Form type USD Million (2019-2024)
  • Table 197. Simvastatin: by Type(USD/Units)
  • Table 198. Research Programs/Design for This Report
  • Table 199. Key Data Information from Secondary Sources
  • Table 200. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Simvastatin: by Type USD Million (2013-2018)
  • Figure 5. Global Simvastatin: by Application USD Million (2013-2018)
  • Figure 6. Global Simvastatin: by Form type USD Million (2013-2018)
  • Figure 7. South America Simvastatin Share (%), by Country
  • Figure 8. Asia Pacific Simvastatin Share (%), by Country
  • Figure 9. Europe Simvastatin Share (%), by Country
  • Figure 10. MEA Simvastatin Share (%), by Country
  • Figure 11. North America Simvastatin Share (%), by Country
  • Figure 12. Global Simvastatin: by Type USD/Units (2013-2018)
  • Figure 13. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 14. Pfizer Inc. (United States) Revenue: by Geography 2018
  • Figure 15. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 16. AstraZeneca (United Kingdom) Revenue: by Geography 2018
  • Figure 17. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Novartis (Switzerland) Revenue: by Geography 2018
  • Figure 19. Merck & Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck & Co. Inc. (United States) Revenue: by Geography 2018
  • Figure 21. Biocon (India) Revenue, Net Income and Gross profit
  • Figure 22. Biocon (India) Revenue: by Geography 2018
  • Figure 23. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2018
  • Figure 25. Concord Biotech (India) Revenue, Net Income and Gross profit
  • Figure 26. Concord Biotech (India) Revenue: by Geography 2018
  • Figure 27. Sun Pharma (India) Revenue, Net Income and Gross profit
  • Figure 28. Sun Pharma (India) Revenue: by Geography 2018
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 31. Global Simvastatin: by Type USD Million (2019-2024)
  • Figure 32. Global Simvastatin: by Application USD Million (2019-2024)
  • Figure 33. Global Simvastatin: by Form type USD Million (2019-2024)
  • Figure 34. South America Simvastatin Share (%), by Country
  • Figure 35. Asia Pacific Simvastatin Share (%), by Country
  • Figure 36. Europe Simvastatin Share (%), by Country
  • Figure 37. MEA Simvastatin Share (%), by Country
  • Figure 38. North America Simvastatin Share (%), by Country
  • Figure 39. Global Simvastatin: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Pfizer Inc. (United States)
  • AstraZeneca (United Kingdom)
  • Novartis (Switzerland)
  • Merck & Co. Inc. (United States)
  • Biocon (India)
  • GlaxoSmithKline Plc. (United Kingdom)
  • Concord Biotech (India)
  • Sun Pharma (India)
  • Abbott Laboratories (United States)
Additional players considered in the study are as follows:
Shandong Lukang Pharmaceutical Co., Ltd (China) , Zhejiang Ruibang (China) , Aurobindo Pharma Ltd. (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation